Log In
BCIQ
Print this Print this
 

ASN002

  Manage Alerts
Collapse Summary General Information
Company Asana BioSciences LLC
DescriptionAntibody-drug conjugate inhibitor of spleen tyrosine kinase (SYK) and the Janus kinase family of proteins formulated using Mersana Therapeutics Inc.'s Dolaflexin platform
Molecular Target Spleen tyrosine kinase (SYK)
Mechanism of ActionAntibody-drug conjugate; Syk kinase inhibitor
Therapeutic ModalityBiologic: Antibody-drug conjugate

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today